Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.63 USD | +3.58% | +7.57% | +23.92% |
Evolution of the average Target Price on Lexeo Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Lexeo Therapeutics, Inc.
RBC Capital Markets | |
Chardan Research | |
JPMorgan Chase | |
Stifel Nicolaus |
EPS Revisions
- Stock Market
- Equities
- LXEO Stock
- Consensus Lexeo Therapeutics, Inc.